Schedule 13G ownership disclosure

SORRENTO THERAPEUTICS IN

Security class unavailable · CUSIP: 83587F202

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,692,730
Percent of class
5.1200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-018594
Form type
SC 13G
Filer
Sorrento Therapeutics, Inc.
CIK
CIK 850261
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub